5-methyl-3-((4-oxo-4H-pyrido[1,2-a]pyrimidin-2-yl)methyl)-5-phenylimidazolidine-2,4-dione

Catalog No. :
ACTDFU391
CAS No. :
1170362-02-3
Molecular Formula :
C19H16N4O3
Molecular Weight :
348.36

IUPAC Name:5-methyl-3-((4-oxo-4H-pyrido[1,2-a]pyrimidin-2-yl)methyl)-5-phenylimidazolidine-2,4-dione

5-methyl-3-((4-oxo-4H-pyrido[1,2-a]pyrimidin-2-yl)methyl)-5-phenylimidazolidine-2,4-dione structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-methyl-3-((4-oxo-4H-pyrido[1,2-a]pyrimidin-2-yl)methyl)-5-phenylimidazolidine-2,4-dione
IUPAC Name5-methyl-3-((4-oxo-4H-pyrido[1,2-a]pyrimidin-2-yl)methyl)-5-phenylimidazolidine-2,4-dione
Molecular FormulaC19H16N4O3
Molecular Weight348.36
SMILESCC1(C2=CC=CC=C2)NC(=O)N(CC2=CC(=O)N3C=CC=CC3=N2)C1=O
InChI KeyCOBUSTRHKLEMAA-UHFFFAOYSA-N
Synonym5-methyl-3-({4-oxo-4H-pyrido[1,2-a]pyrimidin-2-yl} methyl)-5-phenylimidazolidine-2,4-dione;2,4-Imidazolidinedione, 5-methyl-3-[(4-oxo-4H-pyrido[1,2-a]pyrimidin-2-yl)methyl]-5-phenyl-
CAS No.1170362-02-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACTDFU391 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACMHXO083 route compound structure diagram
    ACMHXO0836843-49-8 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTDFU391 route product structure diagram
    ACTDFU3911170362-02-3
Inquiry

2. ACTDFU391 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTDFU391 route product structure diagram
    ACTDFU3911170362-02-3
Inquiry

Comments (0)